Back to search

Article

The TREM2 targeting small molecule Sob-AM2 improves cognition independent of Aβ plaque alteration in 5xFAD mice

2026-08-05

Abstract excerpt

<h4>Background</h4> Inflammation is an early event that substantially influences Alzheimer’s disease (AD) pathogenesis, making it a compelling target for therapeutic intervention. Sob-AM2 is a brain-penetrating thyromimetic drug capable of inducing the expression of microglial cell surface receptor TREM2, which mediates the switch from pro-inflammatory to a more restorative microglial state. <h4>Objective</h4> E...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9fa4d6bc-f134-5641-b8bf-1e9d1d1511d8
DOI
10.64898/2026.07.31.741838
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The TREM2 targeting small molecule Sob-AM2 improves cognition independent of Aβ plaque alteration in 5xFAD miceDOI 10.64898/2026.07.31.741838
Select a neighboring publication to make it the new centre.